Case of unfair diagnosis Flashcards
activation of transmembrane tyrosine kinase receptors?
growth factor binds to receptor causing dimerisation and autophosphorylation causing downstream activation of signalling cascade
mutations causing dysregulation of tyrosine kinase receptor?
ligand independent firing, autocrine growth factors
which tyrosine kinase growth factors are altered in human tumours?
erb b2, her2, neu, egfr
common mechanism of resistance to TKIs?
T790 mutation
first line for tyrosine kinase mutations?
osimertinib
lung cancers can often present with?
recurrent chest infections
pleural effusion
how to geta biopsy for lung cancer?
EBUS and tbna
appearance of adenocarcinoma?
located peripherally columnar glandular cells
BerEP4+, MOC31+, TTF-1 markers
associated with. EGFR, ALK, PDL1 ROS1 changes
lymphovascular invasion- which is why they have hilar lymph nodes involved
squamous cell carcinoma signs?
centrally, bronchial trees, squamous cell keratinisation, desmosomes
p40+. p63+, CK5/6+
PDL1 mutation
cavitate and sometime haemorrhage
small cell (neuroendocrine cells)
very blue cells, small cells, smudged nuclei
CD56, chromogranin positive
TTF1 nuclear - usually present in lungs
mesothelioma?
WT-1, calretinin positive
TTF-1, MOC31, napsin, p40 negative
aggressive, encasement of lung
Metastasis to the lungs?
colon- CK20, CDX-2, SATB2 positive
Breast- ER/PR, GATA3 positive
Prostate- PSA positive
Melanoma- s-100, melan A, SOX-10
usually bilateral multiple, appearance like origin, sharply outlined, rapidly growing and necrotic
lymphangitic carcinomatosis
pseudogenes?
shares a large amount of DNA with another gene
14 hallmarks of cancer?
sustain proliferative signalling
deregulating cellular metabolism
resisting cell death
genome instability and mutation
inducing or accessing vasculature
activating invasion and metastasis
tumour promoting inflammation
enabling replicative immortality
avoiding immune destruction
evading growth suppressors
senescent cells
polymorphic microbiomes
nonmutational epigenetic reprogramming
unlocking phenotypic plasticity
MEN2 is caused by which gene mutation?
RET
medullary thyroid cancer -90%
phaechromocytoma-50
parathyroid adenoma- 20-30%
familial medullary thyroid cancer- 100% risk
MEN2B?
same risk for medullary thyroid/phaechromocytoma
but other abnormalities 40-40
mucosal neuromas
marfanoid
toxic megacolon
>95%= always de novo
most frequent somatic mutation?
LOF- TP53 85% of tumours
most frequent somatic mutation?
LOF- TP53 85% of tumours somatic
BRCA1 is?
more common as germline
BRCA1?
BREAST CANCER ER NEGATIVE 80% OF THE TIME
Li Fraumeni syndrome?
inherited alteration in TP53
role of TP53?
DMA damage repair
induction of apoptosis
cellular metabolism
transcription
induction of G1 arrest
treatment for angiogenesis?
inhibitors of VEGF signalling
treatment for invasion/metastasis?
inhibitors of HGF/c-met
treatment for promoting inflammtion?
selective anti-inflammatory drugs
target for replicative immortality?
telomerase inhibitors
target for avoiding immune destruction
immune activating anti-CTLA4 mAB
target for evading growth suppressors?
cyclin-dependent kinase inhibitors
target for proliferative signaling?
EGFR inhibitors
target for deregulating cellular epigenetics?
aerobic glycolysis inhibitors
target for resisting cell death?
proapototic BH3 mimetics
target for genome instability?
PARP inhibitors